|
Volumn 36, Issue 3, 2002, Pages 321-326
|
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: A phase I/II trial
|
Author keywords
High dose; Radiotherapy; SCLC; Stem cell
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
ETOPOSIDE;
IFOSFAMIDE;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BLOOD TRANSFUSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CHRONOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG MEGADOSE;
ESOPHAGITIS;
FEMALE;
FOLLOW UP;
GRANULOCYTOPENIA;
HUMAN;
INFECTION;
KIDNEY DISEASE;
LEUKOPENIA;
LUNG SMALL CELL CANCER;
MALE;
MULTIMODALITY CANCER THERAPY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
STEM CELL;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, SMALL CELL;
CHI-SQUARE DISTRIBUTION;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
ETOPOSIDE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PROSPECTIVE STUDIES;
RADIOTHERAPY DOSAGE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0036247773
PISSN: 01695002
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-5002(01)00487-1 Document Type: Article |
Times cited : (2)
|
References (25)
|